19-13286525-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001127222.2(CACNA1A):āc.3531C>Gā(p.Pro1177Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,492,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00032 ( 0 hom., cov: 30)
Exomes š: 0.000080 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 synonymous
NM_001127222.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.436
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 19-13286525-G-C is Benign according to our data. Variant chr19-13286525-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 387224.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=3}.
BP7
Synonymous conserved (PhyloP=0.436 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000322 (49/152092) while in subpopulation AFR AF= 0.00101 (42/41496). AF 95% confidence interval is 0.000769. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 49 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.3531C>G | p.Pro1177Pro | synonymous_variant | 20/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.3531C>G | p.Pro1177Pro | synonymous_variant | 20/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.3543C>G | p.Pro1181Pro | synonymous_variant | 20/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.3537C>G | p.Pro1179Pro | synonymous_variant | 20/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.3393C>G | p.Pro1131Pro | synonymous_variant | 19/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.3543C>G | p.Pro1181Pro | synonymous_variant | 20/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.3537C>G | p.Pro1179Pro | synonymous_variant | 20/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.3534C>G | p.Pro1178Pro | synonymous_variant | 20/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 151974Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
49
AN:
151974
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000139 AC: 24AN: 172470Hom.: 0 AF XY: 0.0000765 AC XY: 7AN XY: 91494
GnomAD3 exomes
AF:
AC:
24
AN:
172470
Hom.:
AF XY:
AC XY:
7
AN XY:
91494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000799 AC: 107AN: 1339996Hom.: 0 Cov.: 24 AF XY: 0.0000757 AC XY: 50AN XY: 660118
GnomAD4 exome
AF:
AC:
107
AN:
1339996
Hom.:
Cov.:
24
AF XY:
AC XY:
50
AN XY:
660118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000322 AC: 49AN: 152092Hom.: 0 Cov.: 30 AF XY: 0.000336 AC XY: 25AN XY: 74332
GnomAD4 genome
AF:
AC:
49
AN:
152092
Hom.:
Cov.:
30
AF XY:
AC XY:
25
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 08, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 26, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 14, 2017 | - - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CACNA1A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 22, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at